A detailed history of Prudential Financial Inc transactions in Opti Nose, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 49,200 shares of OPTN stock, worth $25,092. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,200
Previous 44,600 10.31%
Holding current value
$25,092
Previous $46,000 30.43%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.67 - $1.27 $3,082 - $5,842
4,600 Added 10.31%
49,200 $32,000
Q2 2024

Aug 13, 2024

BUY
$0.82 - $1.44 $6,691 - $11,750
8,160 Added 22.39%
44,600 $46,000
Q4 2023

Feb 13, 2024

BUY
$1.02 - $1.47 $26,520 - $38,220
26,000 Added 249.04%
36,440 $47,000
Q3 2023

Nov 13, 2023

BUY
$0.93 - $1.38 $9,709 - $14,407
10,440 New
10,440 $12,000

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $42.5M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.